Author:
Petsky Helen L,Cates Chris J,Kew Kayleigh M,Chang Anne B
Abstract
BackgroundAsthma guidelines guide health practitioners to adjust treatments to the minimum level required for asthma control. As many people with asthma have an eosinophilic endotype, tailoring asthma medications based on airway eosinophilic levels (sputum eosinophils or exhaled nitric oxide, FeNO) may improve asthma outcomes.ObjectiveTo synthesise the evidence from our updated Cochrane systematic reviews, for tailoring asthma medication based on eosinophilic inflammatory markers (sputum analysis and FeNO) for improving asthma-related outcomes in children and adults.Data sourcesCochrane reviews with standardised searches up to February 2017.Study selectionThe Cochrane reviews included randomised controlled comparisons of tailoring asthma medications based on sputum analysis or FeNO compared with controls (primarily clinical symptoms and/or spirometry/peak flow).ResultsThe 16 included studies of FeNO-based management (seven in adults) and 6 of sputum-based management (five in adults) were clinically heterogeneous. On follow-up, participants randomised to the sputum eosinophils strategy (compared with controls) were significantly less likely to have exacerbations (62 vs 82/100 participants with ≥1 exacerbation; OR 0.36, 95% CI 0.21 to 0.62). For the FeNO strategy, the respective numbers were adults OR 0.60 (95% CI 0.43 to 0.84) and children 0.58 (95% CI 0.45 to 0.75). However, there were no significant group differences for either strategy on daily inhaled corticosteroids dose (at end of study), asthma control or lung function.ConclusionAdjusting treatment based on airway eosinophilic markers reduced the likelihood of asthma exacerbations but had no significant impact on asthma control or lung function.
Funder
National Health and Medical Research Council
Programme Grants for Applied Research
Asthma Australia
Subject
Pulmonary and Respiratory Medicine
Reference43 articles.
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017 http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/ (accessed Nov 2017).
2. British Thoracic Society (BTS)/Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma—a national clinical guideline. 2016 https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016.
3. National Asthma Council, Australia. Asthma Management Handbook Melbourne. 2016 http://www.asthmahandbook.org.au (accessed July 2017).
4. The health economics of asthma and rhinitis. I. Assessing the economic impact
5. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献